TA
DGX icon

Tamarack Advisers’s Quest Diagnostics DGX Stock Holding History

Tamarack Advisers’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-376
Closed -$39K – 37
2017
Q2 		$39K Buy
+376
New +$39.8K 0.02% 33

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Tamarack Advisers's DGX Position: Q3 2021 in Review

Tamarack Advisers sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 15,000 shares — an estimated $1.98M sold.

Tamarack Advisers first reported a position in DGX in Q4 2015 and held it in 14 quarters. The position peaked at $46.2M in Q4 2015. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Tamarack Advisers reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
  • Tamarack Advisers sold 15,000 Quest Diagnostics shares in Q3 2021, an estimated $1.98M.
  • Tamarack Advisers first reported a position in Quest Diagnostics in Q4 2015 and held it in 14 quarters.
  • Tamarack Advisers's Quest Diagnostics position peaked at $46.2M in Q4 2015.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Tamarack Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.